Samrat Pharmachem Limited (BOM:530125)
India · Delayed Price · Currency is INR 324.95
0.00 (0.00%)
At close: Sep 1, 2025
Samrat Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Cash & Equivalents | - | 1.65 | 96.68 | 118.62 | 147.05 | 25.06 | Upgrade |
Short-Term Investments | - | 3.6 | 0.11 | 0.14 | 0.1 | 0.01 | Upgrade |
Cash & Short-Term Investments | 5.24 | 5.24 | 96.78 | 118.76 | 147.15 | 25.07 | Upgrade |
Cash Growth | -94.62% | -94.58% | -18.50% | -19.29% | 487.00% | 113.73% | Upgrade |
Accounts Receivable | - | 565.36 | 692.78 | 516.75 | 435.75 | 330.05 | Upgrade |
Other Receivables | - | 0.18 | 0.2 | 0.18 | 0.31 | 3.18 | Upgrade |
Receivables | - | 565.54 | 692.97 | 516.93 | 436.2 | 333.41 | Upgrade |
Inventory | - | 380.05 | 206.77 | 325.28 | 124.16 | 114 | Upgrade |
Prepaid Expenses | - | - | 0.49 | 0.4 | 0.17 | 0.23 | Upgrade |
Other Current Assets | - | 82.77 | 28.66 | 29.17 | 4.93 | 0.54 | Upgrade |
Total Current Assets | - | 1,034 | 1,026 | 990.53 | 712.61 | 473.24 | Upgrade |
Property, Plant & Equipment | - | 104.65 | 107.16 | 106.95 | 99.77 | 93.94 | Upgrade |
Long-Term Investments | - | 73.81 | 69.78 | 59.26 | 25.63 | - | Upgrade |
Other Intangible Assets | - | 0.15 | 0.07 | 0.08 | 0.09 | 0.09 | Upgrade |
Other Long-Term Assets | - | - | 11.83 | 6.65 | 5.97 | 4.65 | Upgrade |
Total Assets | - | 1,215 | 1,217 | 1,166 | 846.12 | 573.97 | Upgrade |
Accounts Payable | - | 385.62 | 476.68 | 318.8 | 233.92 | 176.49 | Upgrade |
Accrued Expenses | - | - | 1.21 | 0.49 | 8.9 | 1.84 | Upgrade |
Short-Term Debt | - | 99.15 | 84.55 | 186.59 | 75.2 | 87.94 | Upgrade |
Current Income Taxes Payable | - | 9.41 | - | 21.35 | 55.28 | 6.75 | Upgrade |
Other Current Liabilities | - | 1.65 | 1.59 | 4.67 | - | 0.26 | Upgrade |
Total Current Liabilities | - | 495.83 | 564.03 | 531.91 | 373.29 | 273.27 | Upgrade |
Long-Term Deferred Tax Liabilities | - | 1.11 | 3.36 | 2.54 | 4.61 | 4.33 | Upgrade |
Other Long-Term Liabilities | - | - | - | - | - | -0 | Upgrade |
Total Liabilities | - | 496.94 | 567.39 | 534.45 | 377.9 | 277.6 | Upgrade |
Common Stock | - | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | Upgrade |
Retained Earnings | - | 687.11 | 619.07 | 600.54 | 437.32 | 265.47 | Upgrade |
Shareholders' Equity | 718 | 718 | 649.97 | 631.43 | 468.22 | 296.37 | Upgrade |
Total Liabilities & Equity | - | 1,215 | 1,217 | 1,166 | 846.12 | 573.97 | Upgrade |
Total Debt | 99.15 | 99.15 | 84.55 | 186.59 | 75.2 | 87.94 | Upgrade |
Net Cash (Debt) | -93.91 | -93.91 | 12.24 | -67.83 | 71.95 | -62.87 | Upgrade |
Net Cash Per Share | -30.38 | -30.39 | 3.96 | -21.95 | 23.29 | -20.35 | Upgrade |
Filing Date Shares Outstanding | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | Upgrade |
Total Common Shares Outstanding | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | Upgrade |
Working Capital | - | 537.78 | 461.65 | 458.62 | 339.32 | 199.97 | Upgrade |
Book Value Per Share | 232.02 | 232.02 | 210.37 | 204.37 | 151.54 | 95.92 | Upgrade |
Tangible Book Value | 717.86 | 717.86 | 649.9 | 631.36 | 468.13 | 296.28 | Upgrade |
Tangible Book Value Per Share | 231.97 | 231.97 | 210.35 | 204.34 | 151.51 | 95.89 | Upgrade |
Land | - | - | 0.89 | 0.89 | 0.89 | 0.89 | Upgrade |
Buildings | - | - | 63.29 | 63.29 | 63.29 | 63.16 | Upgrade |
Machinery | - | - | 101.1 | 97.46 | 83.86 | 75.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.